Updated overall survival (os) outcomes fromthe phase 3 phoebe trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with her2positive metastatic breast cancer

The Breast(2023)

引用 0|浏览7
暂无评分
关键词
pyrotinib plus capecitabine,breast cancer,lapatinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要